Waterdrop Inc. to Report Third Quarter 2024 Financial Results on December 11, 2024
BEIJING, Nov. 27, 2024 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2024, before U.S. markets open on Wednesday, December 11, 2024. Waterdrop's management team will hold a conference call on December 11,...
Tanoto Foundation Enhances Students’ Literacy and Numeracy Through Early Childhood and Basic Education Interventions
SINGAPORE, Nov. 27, 2024 /PRNewswire/ -- The 2022 Programme for International Student Assessment (PISA) survey revealed concerning results for Indonesian students, with low rankings in literacy and numeracy. Indonesia's performance, which declined by 12-13 points in reading, mathematics, and science, is influenced by various factors, including early childhood development and the quality of basic education. Early childhood development, particularly in...
Kelun-Biotech’s TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC
CHENGDU, China, Nov. 27, 2024 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from National Medical Products Administration (NMPA) for the first domestically developed trophoblast cell-surface antigen 2 (TROP2)-directed antibody–drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) for adult patients with unresectable locally advanced or metastatic triple negative breast cancer (TNBC) who have...
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results
Maintained Operational Profitability for the Third Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoY Held Positive Operating Cash Flow for Three Consecutive Quarters SHANGHAI, Nov. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare...
8 in 10 say a healthier diet is important to support mental and physical health – Herbalife Asia Pacific survey
HONG KONG, Nov. 27, 2024 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released findings from its Asia Pacific "New Year, New Me" survey, which revealed that 85% of consumers say a healthier diet is important to support their mental and physical health. Almost eight in 10 (77%)...
VectorBuilder and Sartorius Sign Strategic Cooperation Agreement to Advance Biopharmaceutical Innovation
GUANGZHOU, China, Nov. 26, 2024 /PRNewswire/ -- VectorBuilder, a global leader in end-to-end gene delivery services, and Sartorius, a leading international partner in life science research and the biopharmaceutical industry, recently announced a strategic cooperation agreement. The collaboration will focus on gene vector and mRNA bioprocess solutions and services, accelerating the development and clinical translation of innovative biopharmaceutical projects. ...
IMG Releases 2024 Holiday Travel Trends
IMG has reviewed a sample of member data including more than 17,000 travel itineraries of travelers with upcoming travel plans between Thanksgiving Day and New Year's Day to determine emerging travel trends this holiday season. INDIANAPOLIS, Nov. 26, 2024 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits...
Hankyung.com introduces: ES Technology, the only domestic manufacturer of electric lift, increase the efficiency of specialized equipment such as medical devices and cooperative robots
SEOUL, South Korea, Nov. 26, 2024 /PRNewswire/ -- It is a company that presents ergonomic systems to the industry with the vision of "a company that pursues a convenient life for mankind through automation." Based on more than 24 years of accumulated experience and know-how, it is the only electric lift manufacturing company in Korea that provides the highest-quality...
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
SINGAPORE, Nov. 26, 2024 /PRNewswire/ -- QDX proudly announces that the team led by its co-founder, Associate Professor Giuseppe Barca, has been honoured with the 2024 ACM Gordon Bell Prize, often referred to as the "Nobel Prize of high-performance computing." This accolade recognizes their groundbreaking work in quantum chemistry simulations, which is set to revolutionize QDX's drug discovery technology....
Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU® (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic...
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC. Updated results of elacestrant in combination with abemaciclib show favorable efficacy regardless of the ESR1 mutation status, with a manageable and predictable safety profile in patients with ER+/HER2- mBC. FLORENCE, Italy and NEW YORK,...
